1. Home
  2. ENTA vs ZJYL Comparison

ENTA vs ZJYL Comparison

Compare ENTA & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • ZJYL
  • Stock Information
  • Founded
  • ENTA 1995
  • ZJYL 2006
  • Country
  • ENTA United States
  • ZJYL China
  • Employees
  • ENTA N/A
  • ZJYL N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • ZJYL Industrial Specialties
  • Sector
  • ENTA Health Care
  • ZJYL Consumer Discretionary
  • Exchange
  • ENTA Nasdaq
  • ZJYL Nasdaq
  • Market Cap
  • ENTA 154.0M
  • ZJYL 127.4M
  • IPO Year
  • ENTA 2013
  • ZJYL 2023
  • Fundamental
  • Price
  • ENTA $5.59
  • ZJYL $0.72
  • Analyst Decision
  • ENTA Buy
  • ZJYL
  • Analyst Count
  • ENTA 4
  • ZJYL 0
  • Target Price
  • ENTA $17.25
  • ZJYL N/A
  • AVG Volume (30 Days)
  • ENTA 228.9K
  • ZJYL 323.3K
  • Earning Date
  • ENTA 05-05-2025
  • ZJYL 05-03-2025
  • Dividend Yield
  • ENTA N/A
  • ZJYL N/A
  • EPS Growth
  • ENTA N/A
  • ZJYL 18.46
  • EPS
  • ENTA N/A
  • ZJYL 0.02
  • Revenue
  • ENTA $66,590,999.00
  • ZJYL $23,502,010.00
  • Revenue This Year
  • ENTA N/A
  • ZJYL N/A
  • Revenue Next Year
  • ENTA N/A
  • ZJYL N/A
  • P/E Ratio
  • ENTA N/A
  • ZJYL $29.90
  • Revenue Growth
  • ENTA N/A
  • ZJYL 18.57
  • 52 Week Low
  • ENTA $4.71
  • ZJYL $0.59
  • 52 Week High
  • ENTA $17.80
  • ZJYL $4.65
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 31.66
  • ZJYL 41.94
  • Support Level
  • ENTA $5.65
  • ZJYL $0.66
  • Resistance Level
  • ENTA $5.96
  • ZJYL $0.74
  • Average True Range (ATR)
  • ENTA 0.36
  • ZJYL 0.09
  • MACD
  • ENTA -0.15
  • ZJYL -0.02
  • Stochastic Oscillator
  • ENTA 4.77
  • ZJYL 8.17

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

Share on Social Networks: